Creative Biolabs has expanded its research and development services for edible plant-derived extracellular vesicles (PDEVs), including exosome-like nanovesicles (PELNVs), the company announced. The Shirley, New York-based provider now offers custom workflows covering isolation, purification, characterization, cargo loading, and preclinical evaluation of vesicles sourced from edible plants.
The expansion reflects rising scientific interest in PDEVs as alternative nanoscale delivery systems. According to the company, these vesicles are being investigated because of their natural origin, potential scalability, and reported biocompatibility in experimental models. However, their composition and functional properties can vary substantially depending on the plant source, isolation method, and preparation conditions.
Creative Biolabs has tailored its services to specific plant sources, each with distinct research applications. For skin biology and tissue-repair research, Strawberry-derived EVs are being studied for oxidative-stress, skin biology, and tissue-repair applications, including antioxidant-associated cargos and cellular responses relevant to extracellular-matrix biology. For oral delivery and gastrointestinal research, Grapefruit-derived EVs have been investigated for oral-delivery applications, including vesicle stability under gastrointestinal conditions and potential use as experimental carriers for intestinal delivery. In inflammation, microbial, and immune research, Garlic-derived EVs are being studied for their molecular cargo and potential effects on inflammatory, microbial, and immune-related pathways.
The service platform supports the entire experimental pipeline. It includes isolation and purification of crude plant extracts, multi-dimensional characterization using NTA, TEM, and WB, experimental cargo loading for small molecules, siRNAs, and peptides, and subsequent in vitro and in vivo biological activity assessments.
"Plant-derived extracellular vesicles are attracting growing research interest because their composition and biological properties can vary substantially across plant sources," stated a scientist at Creative Biolabs. "A systematic workflow for isolation, characterization, cargo loading, and functional evaluation can help researchers compare these vesicles and investigate their potential in different experimental applications."
The move matters for researchers exploring plant-derived vesicles as biological nanoparticles and experimental delivery systems. By offering standardized, customizable services across multiple edible plant sources, Creative Biolabs aims to help scientists compare vesicles and accelerate preclinical studies. The company notes its services are for research use only and not for diagnostic or therapeutic procedures. More information is available at https://www.creative-biolabs.com/exosome/.
